Platform Technology Company Customers Resources Support Customers BAYER CROP SCIENCE Brianna White, Head of Trait Design and Science After evaluating the technology landscape, it became clear that the Berkeley Lights Platform is uniquely positioned to enable Bayer Crop Science to deliver on our commitment for world-class innovation and standards in sustainability for farmers, consumers and the environment. Our agreement with Berkeley Lights to develop and perform high-throughput functional screening workflows will enable us to accelerate and expand our trait discovery program. Customer Spotlight 09.16.21 Medical College of Wisconsin on T Cell Characterization Customer Spotlight 06.03.21 Genovac on Antibody Discovery Customer Spotlight 10.29.20 Abveris on Antibody Discovery Customer Spotlight 09.24.20 Amgen on Antibody Discovery and Cell Line Development Customer Spotlight 08.13.20 Catalent Biologics on Cell Line Development Publications Defining variant-resistant epitopes targeted by SARS-CoV-2 antibodies: A global consortium study Bispecific antibodies targeting distinct regions of the spike protein potently neutralize SARS-CoV-2 variants of concern Foundational Tools for Building a New Bioeconomy Microfluidic chip-based single-cell cloning to accelerate biologic production timelines High-throughput optofluidic screening for improved microbial cell factories via real-time micron-scale productivity monitoring Structural basis for SARS-CoV-2 neutralizing antibodies with novel binding epitopes Ultrapotent bispecific antibodies neutralize emerging SARS-CoV-2 variants Limited Mitochondrial Activity Coupled With Strong Expression of CD34, CD90 and EPCR Determines the Functional Fitness of ex vivo Expanded Human Hematopoietic Stem Cells A singular view of COVID-19 Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein Assuring Clonality on the Beacon Digital Cell Line Development Platform Nanoscale Integration of Single Cell Biologics Discovery Processes Using Optofluidic Manipulation and Monitoring Rapid single B cell antibody discovery using nanopens and structured light Multiparameter cell characterization using nanofluidic technology facilitates real-time phenotypic and genotypic elucidation of intratumor heterogeneity A Novel Mammalian Cell Line Development Platform Utilizing Nanofluidics and OptoElectro Positioning Technology Light-Activated Cell Identification and Sorting (LACIS): A New Method to Identify and Select Edited Clones on a Microfluidic Device Customer Videos Lessons Learned from 2+ Years of Discovering Functional Antibodies on the Beacon Abveris on important lessons learned through using the Beacon system for antibody discovery. Accelerating Cell Culture Development through Practical Application of Innovative Technologies Thermo Fisher Scientific on developing a faster, more efficient, and regulatory ready cell line and cell culture. Get to IND Faster: Accelerated & High Performance Cell Line Development Samsung Biologics on how to expedite development timeline and obtain IND clearance and starting phase 1 study faster. Leveraging Innovative Technologies to Accelerate Biologics Development Thermo Fisher Scientific on how to get more molecules to the clinic faster. Characterizing T Cell Functionality on the Berkeley Lights Lightning Platform Medical College of Wisconsin on how to determine the phenotypic and functional characteristics of cells in real time, isolate specific cells of interest, and link the genomic profiles of these same cells using downstream assays. Looking to the Future: What’s next in Antibody Therapeutics Abveris, Genovac, and Berkeley Lights on the evolving landscape of antibody therapeutics, the technologies they have turned to to address today’s complex targets, and how they are preparing for tomorrow’s challenges. Tackle Difficult Targets by Accessing Broad B Cell Diversity Genovac on how to find 10 times more lead candidates than hybridoma in just days. A Beacon for Rapid Antibody Discovery against Difficult Targets Genovac and Berkeley Lights on how to rapidly discover antibodies against challenging targets, such as GPCRs, from a variety of different animal species. Every Day Matters – Optimizing COVID-19 Therapies for Manufacturing Nobel Laureate, Dr. James Rothman, Amgen, Catalent-Biologics, and University of Queensland on fast-tracking the development of therapeutic antibodies and vaccines for SARS-CoV-2. Rapid Discovery of Functional Antibodies for SARS-CoV-2 Using the Beacon System Vanderbilt University Medical Center on how to rapidly discover hundres of unique antibodies against SARS-CoV-2. How Pediatric Immune Systems Empower Cancer Immunotherapy Children’s Hospital of Philadelphia shares insight into why children’s T cells help CAR-T cells succeed and how to develop more efficacious therapies. Accelerating Antibody Discovery in the Modern Therapeutic Landscape Abveris on how to accelerate the development of next-generation antibody therapeutics. Platform Company Customers Careers Resources Support Get In Touch General Inquiries info@berkeleylights.com +1 (510) 858-2855 Tech Support techsupport@berkeleylights.com +1 (888) 254-5595 / Ext. 4 Subscribe to our quarterly newsletter, BLI News. Check out our current issue © 2021 Berkeley Lights. All Rights Reserved. Site by Metropolis. Privacy Policy Terms of Use Patents